Search Results

3 search results found

Kytopen Corporation

Cambridge, MA

Biotechnology

Kytopen is developing platforms to accelerate the discovery and manufacturing of next-generation cell & gene therapies. The Flowfect technology offers a scalable, non-viral solution to deliver genetic payloads to cells in order to augment their functionality. The technology also enables continuous... More

Keywords:

Flowfect(R), Non-Viral, Gene Editing, CRISPR delivery, Continuous Processing, cell therapy, Genome Engineering, CAR T-cells, Engineered TCR T-cells
Past Deadline: Mar 4, 2022

Takeda Seeks Startups working on 4 therapeutic areas

partnership

Takeda is looking for new approaches and technologies that can help them address challenges/opportunities in gastroenterology, oncology, neuroscience and rare genetic & hematology.
Synthetic Biology Workshop 2017 - Panel Discussion

September 12, 2017 | Startup Exchange Video | Duration: 47:6

Synthetic Biology Workshop 2017 - Panel Discussion

Filter Results